Overview
OBSOLETE: HIV-related penile cancer is a term that was previously used in medical classification systems to describe penile cancer occurring in men living with HIV (human immunodeficiency virus). This entry is now considered obsolete, meaning it has been retired from current medical coding systems like Orphanet. The condition it described refers to cancer of the penis that develops in the context of HIV infection, where a weakened immune system increases the risk of certain cancers, including those caused by human papillomavirus (HPV). Men living with HIV have a higher risk of developing penile cancer compared to the general population, largely because HIV weakens the body's ability to fight off HPV infections, which are a major cause of penile cancer. Symptoms can include unusual growths, sores, or lumps on the penis, changes in skin color, and in some cases bleeding or discharge. Treatment typically involves surgery, radiation therapy, chemotherapy, or a combination of these approaches, along with antiretroviral therapy to manage HIV. Because this classification is now obsolete, patients and caregivers should work with their medical team to find the most current diagnostic codes and care pathways.
Key symptoms:
A lump, sore, or wart-like growth on the penisA rash or flat, crusty patches on the penisChanges in skin color on the penisThickening of the skin on the penisBleeding from the penis not related to injuryUnusual discharge from under the foreskinSwollen lymph nodes in the groinPain or discomfort in the penisA foul smell from under the foreskin
Adult
Begins in adulthood (age 18 or older)
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: HIV-related penile cancer.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: HIV-related penile cancer at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: HIV-related penile cancer.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: HIV-related penile cancer.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: HIV-related penile cancer.
Start the conversation →Latest news about OBSOLETE: HIV-related penile cancer
No recent news articles for OBSOLETE: HIV-related penile cancer.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What stage is my penile cancer, and what does that mean for my treatment options?,How will my HIV status affect my cancer treatment plan?,Should I change or adjust my HIV medications during cancer treatment?,What are the chances that treatment will be successful in my case?,Will treatment affect my ability to urinate or have sex?,Are there clinical trials I might be eligible for?,What support services are available to help me cope with both HIV and cancer?
Common questions about OBSOLETE: HIV-related penile cancer
What is OBSOLETE: HIV-related penile cancer?
OBSOLETE: HIV-related penile cancer is a term that was previously used in medical classification systems to describe penile cancer occurring in men living with HIV (human immunodeficiency virus). This entry is now considered obsolete, meaning it has been retired from current medical coding systems like Orphanet. The condition it described refers to cancer of the penis that develops in the context of HIV infection, where a weakened immune system increases the risk of certain cancers, including those caused by human papillomavirus (HPV). Men living with HIV have a higher risk of developing penil
At what age does OBSOLETE: HIV-related penile cancer typically begin?
Typical onset of OBSOLETE: HIV-related penile cancer is adult. Age of onset can vary across affected individuals.